Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM (NCT06547619)
๐ฉบ Plain-English Summary (8th-Grade Level)
Women with a history of gestational diabetes mellitus (GDM) are at a 2-fold greater risk for the development of overt cardiovascular disease (CVD) following the effected pregnancy. While subsequent development of type II diabetes elevates this risk, prior GDM is an independent risk factor for CVD morbidity, particularly, within the first decade postpartum. GDM is associated with impaired endothelial function during pregnancy and decrements in macro- and microvascular function persist postpartum, despite the remission of insulin resistance following delivery. Collectively, while the association between GDM and elevated lifetime CVD risk is clear, and available evidence demonstrates a link between GDM and vascular dysfunction in the decade following pregnancy, the mechanisms mediating this persistent dysfunction remain unexamined. The purpose of this investigation is to examine the role of endothelin-1, a potent vasoconstrictor, in aberrant microvascular function in otherwise healthy women with a history of GDM and to identify whether this mechanism is influenced by physical activity and sedentary behavior.
Who can join: Review the eligibility criteria below.
Location: University of Iowa โ Iowa City, Iowa
Age range: 18 Years to 50 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- University of Iowa โ Iowa City, Iowa
๐ Contact the Study Coordinator
Phone: (319) 467-1732
Email: anna-stanhewicz@uiowa.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Gestational Diabetes
- Preventing Obstetric Complications With Dietary Intervention โ Milwaukee, Wisconsin
- Healthy Eating in Women at Risk of Gestational Diabetes โ Quรฉbec, Quebec
- Role of Adipokines in Glucose Regulation During Pregnancy and in Fetal Development โ Sherbrooke, Quebec
- Predicting Dysglycemia in Individuals With Gestational Diabetes Immediately Postpartum Using Continuous Glucose Monitoring โ Calgary, Alberta
- Role of NADPH Oxidase in Microvascular Dysfunction Following GDM โ Iowa City, Iowa
- Gestational Diabetes and Pharmacotherapy (GAP) โ Milwaukee, Wisconsin
Explore by condition: All Gestational Diabetes clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.